I agree that CTIX has the most explosive potential and if I had been younger I would have kept all my shares but since I am now retired, safety has overtaken maximum returns and I weaned myself off most of my CTIX (FOR NOW) to what I feel are safer havens.  I expect to come back to CTIX late in the year.  I know my costs will be astronomical compared to what most here have as a weighted share price, but that will be the cross I bear for taking the safer, less rewarding road at the current time.  I still follow CTIX as closely now as when I had 185K but as you can see that was being absurdly overweighted in this stock.  As everyone knows, #**$ happens in biotech and I don't have the time to recoup my losses if I took a hard hit now. 

CTIX is pumping along just beautifully and I don't think anyone could have asked for a smoother Kevetrin trial or the phenomenal acquisition of PolyMedix.  To me that buy is worth being a subject at the finest MBA schools while many still don't seem to understand the long term financial bonanza that acquisition will bring to CTIX.